Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 2Osteoporosis 1Neoplasms 1Myocardial Ischemia 1Hepatitis C, Chronic 1Heart Diseases 1Fibrosis 1Coronary Disease 1Colonic Neoplasms 1Clinical Stage III Esophageal Adenocarcinoma AJCC v8 1Cardiovascular Diseases 1Carcinoma, Hepatocellular 1Cachexia 1Bone Diseases 1

Interventions

esmolol 1epigallocatechin gallate 1contrast agent BR1 1alpha-Tocopherol 1Viusid 1Sonazoid 1Sodium Chloride 1Simvastatin 1Pentoxifylline 1Metformin 1Iodides 1Everolimus 1Dietary Supplements 1Catechin 1Aspirin 12-chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Fibrosis × Dietary Supplements × Clear all
NCT00502086 2011-02-11

Efficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection.

Catalysis SL

Phase 3 Completed
100 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡